Molecular Templates, Founded by MBiotech Director Leigh Revers, Rings NASDAQ Closing Bell

Molecular Templates, founded by MBiotech Director Leigh Revers, is a clinical stage biopharmaceutical company developing next generation immunotoxins called Engineered Toxin Bodies (ETBs) for cancer treatment. The Company rang the NASDAQ stock market closing bell on Friday, September 1st, 2017.

Read about it via Yahoo Finance here or watch the closing bell here.

Molecular Templates was also listed as one of The Top 5 Best Stocks Under $10 for 2017